Liver transplantation has evolved into a standard treatment that provides full rehabilitation for patients with irreversible acute or chronic liver failure. Donor shortage is a serious problem and remains unsolvable in liver transplantation. Living-related liver transplantation has been successfully implemented as a strategy to solve the donor shortage [1] . Grafts from non-heart-beating donors (NHBD) may also have a potential as a resource to compensate for this situation [2] [3] [4] . The use of NHBD livers may substantially decrease the disparity between the supply of organs donated and the demand of potential recipients waiting for liver transplantation. As another option for expansion of the donor pool, reduced-sized hepatic grafts have been used for split liver transplantation [5, 6] . Hepatic ischemia and reperfusion (HIR) injury is an inevitable event in liver transplantation. Considering the clinical application of reduced-sized grafts from NHBDs, the capability for hepatic regeneration must be investigated in the ischemically damaged liver. To date, only a few studies are available on the regeneration response of ischemically damaged livers [7] [8] [9] [10] [11] .
Hepatocyte growth factor (HGF) is a kringle-containing polypeptide growth factor that has various biologic properties such as mitogenic, motogenic and morphogenic activities [12] [13] [14] [15] . This multifunctional cytokine is a key factor for liver growth and regeneration, and has been shown to have a hepatocyte protective effect in several liver injury models [16 -18] . A naturally occurring variant of HGF lacks 5 consecutive amino acid residues in the first kringle domain [19] . This deletion variant of HGF (dHGF) has a higher mitogenic activity for rat hepatocytes than HGF [19] . It is anticipated that the regeneration response would be delayed after partial hepatectomy of an ischemically damaged liver. Therefore, a means to overcome the disadvantage in hepatic regeneration must be devised in the clinical application of reduced-sized grafts from NHBDs. If exogenous dHGF administration improves the regeneration response and liver function after partial hepatectomy for the ischemically damaged liver, partial liver grafts from NHBDs may relieve the stagnation of available grafts for liver transplantation.
This study was conducted to determine the influence of HIR injury on functional and structural recovery after partial hepatectomy and the effect of dHGF on liver regeneration under those conditions.
Materials and Methods
Male Sprague-Dawley rats, weighing 250 to 280 g, were purchased from Japan SLC (Hamamatsu, Japan) and were maintained with a 12-hour light and dark cycle in a conventional animal facility. The experimental protocols conformed to the criteria of our institution and the National Research Council (U.S.) for the care and use of laboratory animals in research. The animals were fasted for 12 hours before the experiment but were allowed water ad libitum. The surgical procedure was performed under general anesthesia with intraabdominal injection of sodium pentobarbital (25 mg/kg). A total hepatic ischemic model with an extracorporeal portosystemic shunt was used to produce a severe ischemic insult to the whole liver without splanchnic congestion. The liver was skeletonized after laparotomy, and a portosystemic shunt was placed between a cecal branch of the portal vein and a jugular vein using a polyethylene tube of 0.97-mm inner diameter (Natsume Seisakusho Ltd., Tokyo, Japan) [20] . After intravenous injection of sodium heparin (100 IU/kg), animals from each group were subjected to 60 minutes of total hepatic ischemia by cross-clamping the hepatic artery, the portal vein, and the common bile duct with a vascular microclip. A two-thirds hepatectomy was performed just before reperfusion according to the method of Higgins and Anderson [21] . Reperfusion following hepatic ischemia was achieved by removing the microclip. Animals were divided into two groups: the HGF group was given intravenous dHGF (1 mg/kg), and the vehicle control group received vehicle buffer at the end of the period of hepatic ischemia and again 6 hours after reperfusion. The purified dHGF (Snow Brand Milk Products Co. Ltd., Tochigi, Japan) was diluted with sterile sodium citrate buffer (pH 5.5) containing 5 mg/mL alanine and 0.03% polysorbate 80. Animals with two-thirds hepatectomy alone were prepared as nonischemic controls.
For assessment of survival, we used 11 animals in the HGF group and 10 animals in the vehicle control group, and 5 animals were used at each time point considered for laboratory tests. Blood samples were taken from the aorta for measurement of the plasma aspartate aminotransferase (AST), albumin, and HGF levels at 8 hours after reperfusion. The animals were killed immediately thereafter under ether anesthesia, and their livers were removed for histological studies. Another series was used for the measurement of a 5-bromo-2Ј-deoxyuridine (BrdU) labeling index [22] .
Measurement of Plasma AST and Albumin Levels
To assess hepatic parenchymal damage, plasma AST and albumin levels were determined at 8 hours after reperfusion using a Hitachi 736 autoanalyzer (Hitachi Ltd., Tokyo, Japan).
Measurement of Plasma HGF Levels
Blood samples collected in pyrogen-free tubes containing ethylenediaminetetraacetic acid were centrifuged at 1000ϫg for 10 minutes. Plasma samples were stored at Ϫ80°C until HGF assay. Plasma HGF levels at 8 hours after reperfusion were measured using a commercially available enzyme-linked immunosorbent assay kit (Institute of Immunology, Tokyo, Japan) [23] . All samples were tested in duplicate. The plate was read on a microplate reader (EL 340, Bio-tek Instruments, Inc., Winooski, VT) at 492 nm, and the HGF concentration in experimental samples was calculated from a standard curve.
Assay for Labeling Index
BrdU incorporation was measured to determine the level and timing of DNA synthesis during liver regeneration after partial hepatectomy [22] . BrdU (Zymed Laboratories Inc., San Francisco, CA) was intraperitoneally injected at the dose of 40 g/kg 22 hours after a two-thirds hepatectomy. Animals with BrdU injection were killed 2 hours later (24 hours after partial hepatectomy). Each liver was removed and fixed in 10% formalin; 3 m-thick sections were made from liver tissues, embedded in paraffin, and mounted on glass slides. Immunostaining for BrdU was performed with an avidin-biotin-immunoperoxidase method using a staining kit (Zymed Laboratories Inc., San Francisco, CA). The labeling index was determined by counting more than 1000 hepatocyte nuclei in randomly selected fields under a light microscope in a blind fashion.
Morphological Evaluation
The relative wet weights of the liver per unit body weight were calculated. Then the resected liver specimens were fixed in 10% formalin and embedded in paraffin. Sections at 3 m were made and stained with hematoxylin and eosin for histological examination. Blind analysis was done for all histological studies.
Determination of Survival Rate
After the abdominal incision was closed, the rats were provided with food and water ad libitum. The animals were followed up for 7 days after surgery to assess survival.
Statistical Analysis
All values were expressed as the mean Ϯ SD. Statistical evaluation of the biochemical and histological data was performed using analysis of variance and the Newman-Keul test for multiple comparisons. Survival estimated by the Kaplan-Meier method was checked for statistical significance by the log-rank test. A p value of less than 0.05 was considered significant.
Results

Survival Rates for 7 Days after Partial Hepatectomy
In nonischemic controls, all rats survived for 7 days after partial hepatectomy. In the vehicle control group, 5 of 10 rats died within 12 hours after surgery and the 7-day survival rate deteriorated to 40%. Administration of dHGF significantly improved the 7-day survival rate to 82% when compared with that in the vehicle control group (p Ͻ 0.05). (Fig. 1) .
Plasma AST and Albumin Levels
At 8 hours after partial hepatectomy for ischemically damaged liver, plasma AST levels were markedly increased in the vehicle control and HGF groups, while AST levels in the nonischemic controls were 634 Ϯ 183 IU/L. Plasma AST levels in the vehicle control group reached 3462 Ϯ 1039 IU/L, but those in the HGF group were significantly inhibited to 1849 Ϯ 605 IU/L (p Ͻ0.01) (Fig. 2) . Plasma albumin levels in the nonischemic controls, the vehicle control group, and the HGF group were 3.4 Ϯ 0.2 g/dl, 3.3 Ϯ 0.2 g/dl, and 3.3 Ϯ 0.1 g/dl, respectively, without significant differences among the three groups.
Plasma HGF Levels
The plasma HGF levels at 8 hours after partial hepatectomy in the nonischemic controls were 0.407 Ϯ 0.131 ng/ml. The plasma HGF levels in the vehicle control group at the corresponding time were 0.142 Ϯ 0.046 ng/ml. There was a significant difference in plasma HGF level between the nonischemic controls and the vehicle control group (p Ͻ 0.05). (Fig. 3) .
Relative Liver Weight
Relative liver weight at 8 hours after partial hepatectomy in the vehicle control group was significantly increased when compared to the nonischemic controls and the HGF group (p Ͻ 0.01). In contrast, relative liver weight at 24 hours after partial hepatectomy in the vehicle control group was significantly lower than in the nonischemic controls and the HGF group (p Ͻ 0.05). A significant increase in relative liver weight was observed in the nonischemic control and the HGF group with time after surgery (p Ͻ 0.01) ( Table 1 ). There was no significant difference in relative liver weight at 8 and 24 hours after surgery between nonischemic controls and the HGF group.
Histologic Findings
Apparent hepatic necrosis was not seen in the liver at 8 hours after partial hepatectomy in the nonischemic controls. Focal necrosis with sinusoidal congestion and neutrophil accumulation was observed at the midzonal areas in the livers of the vehicle control group at the corresponding time. Less histologic damage was seen in the livers of the HGF group ( Fig. 4A and B) .
Hepatic DNA Synthesis
DNA synthesis of hepatocytes in vivo by BrdU incorporation was assessed 24 hours after partial hepatectomy. Because 6 of 10 animals in the survival study of the vehicle control group died within 24 hours after surgery, determination of hepatic DNA synthesis was not determined for this group. The BrdU labeling index in the HGF group was significantly increased to 22.8 Ϯ 0.4% versus 18.5 Ϯ 1.6% in the nonischemic controls (p Ͻ 0.05) (Fig. 5 ).
Discussion
As a valuable way to solve the serious problem of organ shortage, attention has turned to the use of grafts from NHBDs. A growing number of organ procurement organizations are adopting policies regarding donations from NHBDs [24] . Organ procurement from NHBDs has been performed in either controlled or uncontrolled settings [25] . A controlled setting is one in which the donor family has made the decision to terminate life support, and cardiac arrest is expected to follow upon termination. An uncontrolled setting is one in which cardiac arrest occurs unexpectedly. In the United States the focus is on the controlled setting [26, 27] . Recent reports have described that controlled NHBDs contributed 5% of hepatic allografts in liver transplantation [26, 27] . Their clinical trials demonstrated that NHBDs would significantly and safely expand the donor pool for liver transplantation. It is controversial whether the incidence of primary nonfunction is higher in recipients of livers from NHBDs when compared with recipients from heart-beating donors [26, 27] . Primary nonfunction of a hepatic graft is related to the duration of ischemic time [28] . The mean warm ischemic time in a Wisconsin study was 16.4 minutes, with the longest warm ischemic time extending to 46 minutes [27] . Warm ischemia in the controlled setting is not absolute because of variable periods of hypotension and hypoxia. Therefore, the current protocol in the Wisconsin group is to retrieve extrarenal organs with up to 60 minutes of warm ischemia [27] . We thus selected 60 minutes of total hepatic ischemia as an experimental model in the present study.
Liver regeneration is a physiologic phenomenon that leads to restoration of the hepatic parenchyma after partial hepatectomy and other types of liver injuries. The regenerative capacity of the remnant liver has made it possible to perform liver resection safely in humans. In clinical liver surgery, total hepatic vascular exclusion or cross-clamping of the portal triad has been applied for control of hemorrhage during parenchymal dissection [29, 30] . Huguet and associates [29] indicated that interruption of the hepatic blood flow in normothermia is safe for at least 60 minutes, even without venous bypass to decompress the occluded territory. In an era of organ shortage, application of split liver grafts from NHBD divided between two recipients would increase the chance of recovery from hepatic failure by liver transplantation [5, 6] . However, it is anticipated that ischemia is a critical factor associated with the impaired regenerative capacity of the liver [8] . Data on regeneration of ischemically damaged livers were available in some experimental studies, but the issue of regenerative capacity remains controversial because the differences in regenerative response between normal and ischemically damaged livers have been insufficiently clarified under these conditions [7] [8] [9] [10] .
In experimental studies in rats, a peak of thymidine kinase mRNA was observed 24 hours after two-thirds hepatectomy without any mortality [31] . Selzner et al. [8] demonstrated that ischemia dramatically impaired the regenerative capacity of the liver. Contradictory data [32] have been reported concerning the regenerative response of the liver after ischemic insult. Maruyama and associates [32] indicated that a period of ischemia as long as 60 minutes did not adversely affect hepatic regeneration, and animal survival was achieved even after 90 minutes of ischemia and major hepatectomy. In our previous studies, animals could tolerate well 60 minutes of total hepatic ischemia without a subsequent partial hepatectomy [20, 33] . We confirmed that the regenerative response was impaired after two-thirds hepatectomy using the same ischemic model, and animal survival deteriorated to 40% within 7 days after surgery. In agreement with our results, Yanaga et al. [34] indicated that an allograft of less than 30% of expected full liver volume might lead to primary graft nonfunction in porcine orthotopic liver transplantation. This process is mediated by various factors such as cytokines and growth factors [8, 9, 15] . Considering the clinical application of liver grafts from NHBDs in split-liver transplantation to solve the organ shortage, we sought to determined whether dHGF improves the regenerative capacity in ischemically damaged liver. If so, this may prove to be a useful strategy for promoting regeneration after partial hepatectomy for the ischemically damaged liver in humans.
The present study demonstrated that dHGF has the potential to enhance hepatic regeneration even in the ischemically damaged liver. This pleiotropic substance inhibited the functional deterioration resulting from HIR injury, as well as morphological recovery, which would lead to improved survival after partial hepatectomy for an ischemically damaged liver. HGF has been implicated in antifibrosis, differentiation, and regeneration in liver disease [9, 14 -16, 35, 36] . Recent studies have reported a cytoprotective effect of HGF for hepatocytes in various liver injury models [17, 18] .
The main sources of HGF in the liver are nonparenchymal cells such as Kupffer cells, sinusoidal endothelial cells (SECs), and Ito cells [37, 38] . The plasma HGF concentration has been reported to rise 17-fold as early as 2 hours after two-thirds hepatectomy in rats, long before DNA synthesis begins [15] . An increase in HGF mRNA during liver regeneration has also been observed in the mesenchymal cells of extrahepatic organs such as the lung and the spleen [39] , which may be associated with a rise in plasma HGF levels in the early phase of hepatic regeneration. The expression of HGF mRNA increased in Ito cells 3 to 6 hours after partial hepatectomy and lasted for 24 hours [40] . Because the circulating HGF at 8 hours after two-thirds hepatectomy is derived from liver tissue, plasma HGF levels were compared between nonischemic controls and the vehicle control group in our study. Markedly inhibited HGF levels in the vehicle control group may reflect the impact of HIR injury for regenerative response after two-thirds hepatectomy. It has been reported that hepatic DNA synthesis after two-thirds hepatectomy reached a peak value of 20% to 30% of BrdU labeling index at 24 hours after surgery [22, 23] . The potency of dHGF for regenerative response after two-thirds hepatectomy for the ischemically damaged liver was verified from our results. Hepatic DNA synthesis in the HGF group was maintained at a higher level than in nonischemic controls.
Our previous study demonstrated that tumor necrosis factor-␣, a proinflammatory cytokine, is released primarily from activated Kupffer cells in HIR injury [33] . This mediator propagates the inflammatory response in the liver by stimulating chemokine production and inducing the expression of adhesion molecules on vascular and sinusoidal endothelial cells [41, 42] . The neutrophilendothelial cell interaction with neutrophil adhesion to SECs is essential for the development of HIR injury. Moreover, it has been reported that apoptosis, first of SECs and then of hepatocytes, is an important mechanism of cell death after HIR injury [43] . Thus, attenuation of damage to SECs may result in the improvement of HIR injury. As a salutary action of HGF, recent attention has been focused on its protective effect against SEC injury. Pretreatment with HGF showed a decrease in hyaluronic acid uptake in the field of HIR injury [44, 45] . Takeda and associates [44] demonstrated that addition of HGF to University of Wisconsin solution markedly ameliorated SEC injury. In the present study, the relative liver weight in the vehicle control group 8 hours after partial hepatectomy significantly increased, with focal liver necrosis, sinusoidal congestion, and neutrophil accumulation, when compared with liver weight in the HGF group. In contrast with this situation, relative liver weight 24 hours after two-thirds hepatectomy was markedly augmented in the HGF group. Liver histology in the HGF group in the early phase after two-thirds hepatectomy following hepatic ischemia showed an improvement of hepatic microcirculatory derangement. Although we did not determine hyaluronic acid uptake in the present study, protection against SEC injury may be salutary for amelioration of the regenerative response in the ischemically damaged liver. The significance of our data may be partially supported by results reported by Uchiyama and associates, who found that dHGF augmented regeneration of reduced-size liver grafts [46] .
Because hepatic regenerative response combined with HIR injury is multifactorial, the amelioration of impaired regeneration may be achieved by other cytokines besides HGF. Interleukin-6 is also a key protective molecule in promoting regeneration following combined ischemia and major tissue loss in the liver [8] . Moreover, this inflammatory cytokine induces the expression of signal transducers and activators of transcription 3, which plays a pivotal role in hepatic regeneration [47] . Activation of these signal pathways after the stimulus of hepatectomy may be implicated in the regulation of HGF production. Further studies on the combination therapy of dHGF and interleukin-6, as well as on the optimal administration time of dHGF, may be necessary to produce a more augmented regenerative response in the ischemically damaged liver.
Most laboratory animals, including rodents, have very few spontaneous portosystemic collateral veins, and acute portal vein occlusion results in fatal outcome resulting from rapid cardiovascular collapse [20, 48] . In contrast, humans and primates have a more efficient portosystemic collateral network and tolerate well the clamping of the portal vein [48, 49] . The hemodynamic response in humans may thus be significantly different from that in rodents [48, 49] . In our study, to mimic the condition of total hepatic ischemia in humans, placement of an extracorporeal portosystemic shunt was necessary to prevent splanchnic congestion in the rats. On vascular anatomy of the liver, the branching pattern of the rat portal vein was similar to a rare branching pattern in human livers [50] . Further study is necessary to determine whether our results are applicable to liver transplantation in humans because of the anatomical and hemodynamic differences between humans and rats.
In conclusion, 60 minutes of hepatic ischemia impaired the regeneration response after two-thirds hepatectomy. dHGF has potential as a beneficial pharmacological agent to augment hepatic microcirculation and induce a regeneration response of the ischemically damaged liver after hepatectomy or liver transplantation. Resumen. El estudio fue realizado con el propósito de determinar la influencia de la lesión de isquemia, y reperfusión hepática (IRH) sobre la regeneración del hígado, y el efecto de la deleción variante del factor de crecimiento del hepatocito (dHGF) bajo tales condiciones. Un grupo de ratas Sprague-Dawley fue sometido a 60 minutos de isquemia hepática total. Se practicó una hepatectomía de dos tercios justo antes de la reperfusión. Los animales recibieron por vía intravenosa bien un "buffer" vehicular (grupo control de vehículo), o dHGF (1 mg/kg) (grupo HGF), al final de la isquemia hepática y a las 6 horas después de la reperfusión. A las 8 horas de la hepatectomía los niveles plasmáticos de HGF en el grupo control de vehículo, aparecieron significativamente inferiores que en los controles no isquémicos. Los niveles plasmáticos de la aspartato transaminasa en el grupo control de vehículo alcanzaron valores de 3462 ؎ 1039 UI/L, pero en el grupo HGF se vieron significativamente inhibidos, a niveles de 1849 ؎ 605 UI/L. El peso relativo del hígado en el grupo control de vehículo se vio significativamente aumentado en comparación con el grupo HGF, lo cual fue interpretado como expresión de la necrosis focal del hígado con congestión sinusoidal. Se observó menor daño histológico en el grupo HGF. A las 24 horas de la hepatectomía, el incremento en el peso relativo del hígado en los controles no isquémicos y en el grupo HGF fue mayor que en el grupo control de vehículo, y el índice de marcación del 5-bromo-2 desoxiuridina en el grupo HGF fue de 23% contra 18% en los controles no isquémicos. La administración de dHGF mejoró en forma significativa la tasa de supervivencia a 7 días, a 82%, contra 40% en el grupo control de vehículo. El dHGF exhibe potencial como factor farmacológico benéfico que mejora la alterada microcirculación y la respuesta de regeneración del hígado lesionado por isquemia en la hepatectomía o en el trasplante hepático.
